</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →

Trioxane Pharmaceutical Intermediate from Germany

Trioxane is a heterocyclic compound with oxygen hetero-atoms only, used as an intermediate in pharmaceutical synthesis for antimalarial drugs like artemisinin derivatives. It features a six-membered ring with three oxygen atoms, fitting precisely under HTS 2932.99 for other heterocyclic oxygen compounds not elsewhere specified. This pure chemical compound meets Chapter 29 requirements for separate chemically defined organic compounds.

Duty Rate — Germany → United States

21.3%

Rate breakdown

9903.04.6211.3%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.3910%Except for products described in headings 9903.05.85–9903.05.92 and 9903.05.97, articles the product of a member state of the European Union, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 10 percent, as provided for in U.S. note 52 to this subchapter

Import Tips

Provide detailed chemical analysis certificates confirming heterocyclic structure and oxygen hetero-atoms only to avoid misclassification

Ensure COA (Certificate of Analysis) verifies purity >98% as mixtures may shift to different headings

Label shipments clearly as 'pharmaceutical intermediate - not for direct medicinal use' to comply with FDA import requirements